Zuhre KARSLI, Gulseren PAMUK, Kurtulus ÖNGEL

Evaluation of frailty in individuals aged 65 years and over, with and without diabetes: A cross-sectional study

Aim: This study aims to reveal the effect of frailty in patients aged 65 years and over with and without type 2 diabetes. Materials and Methods: A total of 298 elderly individuals aged 65 and over, 149 type 2 diabetic individuals and 149 non-diabetic individuals as the control group, were included in the descriptive cross-sectional study. Both groups were surveyed using Edmonton Frail Scale and socio-demographic data questionnaire. Results: The mean age of the participants was 70.68±5.45 years, and 63.4% (n=189) of participants were female. Of the diabetic patients, 61 (40.9%) patients were found to be frail, 41 (27.5%) to be prone to frailty, and 47 (31.5%) to be non-frail. In individuals without diabetes, 33 (22.1%) individuals were found to be frail, 22 (14.8%) to be prone to frailty, and 94 (63.1%) to be non-frail. When both groups were analyzed statistically in terms of frailty, it was observed that frailty increased significantly in diabetic patients (p < 0.05). Conclusion: This study has proved that frailty increases in type 2 diabetic patients compared to non-diabetic patients, the perception and assessment of aging may play a role under frailty, and quality of life is one of the factors that should be considered in the development of frailty. The high rates of falling and hospitalization in elderly diabetic patients necessitate taking necessary precautions. Further studies are needed to reveal the pathophysiology of frailty in diabetic elderly patients.

PDF

___

1. Kılıç S, Simsek E, Nalbantgil S, Kırılganlık Sendromu ve Kardiyovasküler Sistem. MN Kardiyoloji 2016;23(4):200-206
2. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001;56(3):M146-56.
3. Collard RM, Boter H, Schoevers RA, Oude Voshaar RC. Prevalence of frailty in community-dwelling older persons: a systematic review. J Am Geriatr Soc. 2012;60(8):1487-92.
4. Yanase T, Yanagita I, Muta K, Nawata H. Frailty in elderly diabetes patients. Endocr J. 2018;65(1):1-11.
5. Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43:748-59.
6. Horstman AM, Dillon EL, Urban RJ, Sheffield-Moore M. The role of androgens and estrogens on healthy aging and longevity. J Gerontol A Biol Sci Med Sci. 2012;67:1140-52
7. Morley JE, Malmstrom TK, Rodriguez-Mañas L, Sinclair AJ. Frailty, sarcopenia and diabetes. J Am Med Dir Assoc. 2014;15:853-9.
8. Kalyani RR, Corriere M, Ferrucci L. Age-related and diseaserelated muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2:819-29.
9. Regidor E, Franch J, Seguí M, Serrano R, Rodríguez-Artalejo F, Artola S. Traditional risk factors alone could not explain the excess mortality in patients with diabetes: a national cohort study of older Spanish adults. Diabetes Care. 2012;35:2503-9.
10. Volpato S, Blaum C, Resnick H, Ferrucci L, Fried LP, Guralnik JM; Women’s Health and Aging Study. Comorbidities and impairments explaining the association between diabetes and lower extremity disability: The Women’s Health and Aging Study. Diabetes Care. 2002;25:678-83.
11. Alemán-Mateo H, López Teros MT, Ramírez FA, Astiazarán- García H. Association between insulin resistance and low relative appendicular skeletal muscle mass: evidence from a cohort study in community-dwelling older men and women participants. J Gerontol A Biol Sci Med Sci. 2014;69:871-7.
12. Park SW, Goodpaster BH, Lee JS, et al. Health, Aging, and Body Composition Study. Excessive loss of skeletal muscle mass in older adults with type 2 diabetes. Diabetes Care. 2009;32:1993-7
13. Yoon JW, Ha YC, Kim KM, et al. Hyperglycemia is associated with impaired muscle quality in older men with diabetes: the Korean Longitudinal Study on Health and Aging. Diabetes Metab J. 2016;40:140-6
14. Cacciatore, F., et al., Clinical frailty and long-term mortality in elderly subjects with diabetes. Acta diabetologica, 2013;50:251- 60.
15. Howrey BT, Al Snih S, Markides KS, Ottenbacher KJ. Frailty and diabetes among Mexican American older adults. Ann Epidemiol. 2018;28:421-426.
16. Rolfson DB, Majumdar SR, Tsuyuki RT, Tahir A, Rockwood K. Validity and reliability of the Edmonton Frail Scale. Age Ageing. 2006;35:526-9.
17. Aygör, H.E., et al., Validation Of Edmonton Frail Scale Into Elderly Turkish Population. Archives of Gerontology and Geriatrics, 2018; 76:133-37.
18. Del Brutto OH, Mera RM, Sedler MJ, Zambrano M, Nieves JL, Cagino K, Fanning KD, Milla-Martinez MF, Castillo PR. The Effect of Age in the Association between Frailty and Poor Sleep Quality: A Population-Based Study in Community-Dwellers (The Atahualpa Project). J Am Med Dir Assoc. 2016;17:269-71.
19. Global Database on Body Mass Index. http://www.assessmentpsychology. com/icbmi.htm World Health Organization - Last update: 11.17.2006
20. Kurtoglu S, Inkaya B. Tip 2 Diyabetus Mellituslu Yaslılarda Kırılganlık ve Öz-Etkililigin Degerlendirilmesi, Gerontoloji Hemsireligi Programı, Yüksek Lisans Tezi, Ankara Yıldırım Beyazıt Üniversitesi Saglık Bilimleri Enstitüsü, Ankara, 2020
21. Regidor E, Franch J, Segui M, et al. Traditional risk factors could not explain the excess mortality in patients with diabetes. Diabetes Care 2012;35:2503-09.
22. Saum KU, Dieffenbach AK, Muller H, Holleczek B, Hauer K, Brenner H. Frailty prevalence and 10-year survival in community- dwelling older adults: results from the ESTHER cohort study. Eur J Epidemiol 2014;29:171-9.
23. Bouillon K, Kivimaki M, Hamer M, Shipley MJ, Akbaraly TN, Tabak A, et al. Diabetes risk factors, diabetes risk algorithms, and the prediction of future frailty: the Whitehall II prospective cohort study. J Am Med Dir Assoc 2013;14:851.
24. Howrey BT, Al Snih S, Markides KS, Ottenbacher KJ. Frailty and diabetes among Mexican American older adults. Ann Epidemiol. 2018;28:421-26.
25. Hubbard, R., et al., Comparison of the prognostic importance of diagnosed diabetes, co-morbidity and frailty in older people. Diabetic Medicine, 2010;27:603-06.
26. Cacciatore, F., et al., Clinical frailty and long-term mortality in elderly subjects with diabetes. Acta diabetologica, 2013;50:251- 60.
27. Morley JE, Malmstrom TK, Rodriguez-Manas L, Sinclair AJ. Frailty, sarcopenia and diabetes. J Am Med Dir Assoc 2014;15:853-9.
28. Kalyani RR, Corriere M, Ferrucci L. Age-related and diseaserelated muscle loss: the effect of diabetes, obesity, and other diseases. Lancet Diabetes Endocrinol. 2014;2:819-29.
29. Ding EL, Song Y, Malik VS, Liu S. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. JAMA. 2006;295:1288-99.
30. Ozfirat Z, Chowdhury TA. Vitamin D deficiency and type 2 diabetes. Postgrad Med J. 2010;86:18-25.
31. Masel, M.C., et al., Frailty and health related quality of life in older Mexican Americans. Health and Quality of Life Outcomes, 2009. 7(1): p. 70.
32. Tilling, L.M., K. Darawil, and M. Britton, Yaslılarda diabetes mellitusun bir komplikasyonu olarak düsmeler. Journal of Diabetes and its Complition, 2006;2:146-51.
33. Rosenthal MJ, Fajardo M, Gilmore S, Morley JE, Naliboff BD. Hospitalization and mortality of diabetes in older adults. A 3- year prospective study. Diabetes Care. 1998;21:231-5.